Why is Avalyn Pharma stock surging today?
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avalyn Pharma Inc (AVLN)
Avalyn Pharma Inc stock price live, this page displays NASDAQ AVLN stock exchange data. View the AVLN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Avalyn Pharma Inc real time stock price chart below.
What Is the Avalyn Pharma Inc Stock Price Today?
The Avalyn Pharma Inc stock price today is 28.06.
What Is the Stock Symbol for Avalyn Pharma Inc?
The stock symbol for Avalyn Pharma Inc is "AVLN."
What Stock Exchange Does Avalyn Pharma Inc Trade On?
Avalyn Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Avalyn Pharma Inc a Good Stock to Buy?
Determining whether Avalyn Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AVLN quote. (ISIN: US05348Y1055)
What Is the Avalyn Pharma Inc Stock Price Today?
The Avalyn Pharma Inc stock price today is 28.06.
What Is the Stock Symbol for Avalyn Pharma Inc?
The stock symbol for Avalyn Pharma Inc is "AVLN."
What Stock Exchange Does Avalyn Pharma Inc Trade On?
Avalyn Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Avalyn Pharma Inc a Good Stock to Buy?
Determining whether Avalyn Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AVLN quote. (ISIN: US05348Y1055)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.12
28.67
52 wk Range
24.15
33.32
AVLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
27.1228.67
52 wk Range
24.1533.32
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AVLN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
59.00
Upside
+110.26%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Why is Avalyn Pharma stock surging today?
- Investing.com
- Avalyn Pharma Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 59.00
(+110.26% Upside)
Earnings
Latest Release
Jun 03, 2026
EPS / Forecast
-21.83 / --
Revenue / Forecast
-- / --
Compare AVLN to Peers and Sector
Metrics to compare | AVLN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVLNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.1x | 14.3x | −0.4x | |
PEG Ratio | - | 0.19 | 0.00 | |
Price/Book | −4.7x | 2.3x | 2.6x | |
Price / LTM Sales | - | 2.4x | 3.0x | |
Upside (Analyst Target) | 81.5% | 226.4% | 51.9% | |
Fair Value Upside | Unlock | 31.2% | 9.1% | Unlock |
Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose combination of inhaled pirfenidone and nintedanib to deliver dual antifibrotic mechanisms. Avalyn Pharma Inc. was formerly known as Genoa Pharmaceuticals, Inc. and changed its name to Avalyn Pharma Inc. in July 2017. The company was incorporated in 2011 and is based in Boston, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Avalyn Pharma (AVLN) Stock Price Today?
The Avalyn Pharma stock price today is 28.06 USD.
What Stock Exchange Does Avalyn Pharma Trade On?
Avalyn Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Avalyn Pharma?
The stock symbol for Avalyn Pharma is "AVLN."
What Is the Avalyn Pharma Market Cap?
As of today, Avalyn Pharma market cap is 1.28B USD.
What Is Avalyn Pharma's Earnings Per Share (TTM)?
The Avalyn Pharma EPS (TTM) is -78.19.
When Is the Next Avalyn Pharma Earnings Date?
Avalyn Pharma will release its next earnings report on Sep 02, 2026.
From a Technical Analysis Perspective, Is AVLN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Avalyn Pharma Stock Split?
Avalyn Pharma has split 0 times.
How Many Employees Does Avalyn Pharma Have?
Avalyn Pharma has 50 employees.
What is the current trading status of Avalyn Pharma (AVLN)?
As of Jul 10, 2026, Avalyn Pharma (AVLN) is trading at a price of 28.06 USD, with a previous close of 28.92 USD. The stock has fluctuated within a day range of 27.12 USD to 28.67 USD, while its 52-week range spans from 24.15 USD to 33.32 USD.
What Is Avalyn Pharma (AVLN) Price Target According to Analysts?
The average 12-month price target for Avalyn Pharma is 59.00 USD, with a high estimate of 80 USD and a low estimate of 51 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +110.26% Upside potential.
What Is the AVLN Premarket Price?
AVLN's last pre-market stock price is 29.35 USD. The pre-market share volume is 17,940.00, and the stock has decreased by 0.43, or 1.49%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.